Hyperuricemia
Conditions
Interventions
Experiment Group A:Uric acid-lowering powder, composed of inulin, Salvia miltiorrhiza extract, turmeric extract, green tea extract and vitamin C, etc. Take once a day, 1 bag each time (containing 6g o
Experiment Group B:Placebo: A simulation agent, with packaging, appearance and odor basically the same as this product. Once a day, 1 bag per time (containing 6g of the product). Placebo refers to a p
Sponsors
Beijing University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
16 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1 Age: 18-65 years old; 2 Simple hyperuricemia: Under a normal purine diet, fasting blood uric acid levels (SUA) on two different days (within one year before screening and at screening) : For the population with simple hyperuricemia, 420 (above) µmol/L<=SUA<=660µmol/L; 3 No gout has occurred in the past month; 4 Have resided in the local area for more than one year; 5 People with stable work and life conditions, free from regular habits such as staying up late, overeating, and excessive social engagements; 6 During the experiment, it is possible to have a fixed and regular diet and lifestyle. 7 Those who sign the informed consent form and volunteer to try.
Exclusion criteria
Exclusion criteria: 1 Those who have taken or are currently taking medications related to the function of lowering uric acid (such as allopurinol, febuxostat, benzbromarone, propanesulfonic acid, thiazides) or health supplements within the past three months, which has affected the judgment of the results; 2 Those who are currently suffering from or have had severe gastrointestinal diseases in the last three months, including colorectal cancer, inflammatory bowel disease, chronic or acute diarrhea, and long-term constipation; Or patients who have undergone gastrointestinal and abdominal surgeries within one year, such as cholecystectomy, etc. 3 Patients who are already accompanied by complications of hyperuricemia, such as gout, joint deformity, renal function impairment, etc. 4 Patients diagnosed with type 1 and type 2 diabetes, severe hypertension and coronary heart disease; 5 Patients with severe heart, liver and kidney dysfunction, mental disorders, infectious diseases, tumors, severe anemia, severe autoimmune diseases such as rheumatoid arthritis and lupus erythematosus, as well as those who have undergone recent surgeries; 6 Those who are allergic to multiple drugs or are known to be allergic to the components of this study product; 7 Currently participating in other clinical trials; 8 Other circumstances that the researchers consider not suitable for inclusion in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood uric acid level;24-hour urine uric acid level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood lipids (TC, TG, LDL, HDL);Fasting blood glucose;Blood pressure (SBP, DBP);BMI; | — |
Countries
China
Contacts
Public ContactLi Lingru
Beijing University of Chinese Medicine/National Research Center for Traditional Chinese Medicine Constitution and Preventive Medicine
Outcome results
None listed